Robert I. Goldfarb - 01 Apr 2023 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Role
Chief Operating Officer
Signature
Robert I. Goldfarb
Issuer symbol
NXEN
Transactions as of
01 Apr 2023
Net transactions value
$0
Form type
4
Filing time
03 Aug 2023, 10:23:54 UTC
Previous filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common Stock Award +250,000 +14% 2,028,000 01 Apr 2023 Direct F1
transaction NXEN Common Stock Award +250,000 +12% 2,278,000 25 Jul 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXEN Options to purchase common stock (right to buy) Award +1,000,000 1,000,000 19 Aug 2020 Common Stock 1,000,000 $0.0800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in lieu of compensation for services.